Advanced Biotherapy Concepts Inc. Files Form 10-KSB.Business Editors WOODLAND HILLS, Calif.--(BUSINESS WIRE)--April 18, 2000 Advanced Biotherapy biotherapy /bio·ther·a·py/ (-ther´ah-pe) biological therapy. bi·o·ther·a·py n. Treatment of disease with biologicals, such as vaccines. Concepts Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :ADVB ADVB Associação dos Dirigentes de Vendas e Marketing do Brasil ) today announced that the company filed its Annual Report on Form 10-KSB on April 11, 2000, within the 15-day extension period provided for by Form 12b-25, Notification of Late Filing, for the year ended Dec. 31, 1999. Advanced Biotherapy Concepts is a development-stage biotechnology company developing treatments for severe autoimmune diseases Autoimmune diseases A group of diseases, like rheumatoid arthritis and systemic lupus erythematosus, in which immune cells turn on the body, attacking various tissues and organs. Mentioned in: Complement Deficiencies, Premature Menopause including rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus Systemic Lupus Erythematosus Definition Systemic lupus erythematosus (also called lupus or SLE) is a disease where a person's immune system attacks and injures the body's own organs and tissues. Almost every system of the body can be affected by SLE. , insulin dependent diabetes and AIDS. The company's technology has already shown promise in published clinical studies. The company's patented and proprietary treatment, which has now been evaluated in approximately 150 patients, neutralizes certain cytokines Cytokines Chemicals made by the cells that act on other cells to stimulate or inhibit their function. Cytokines that stimulate growth are called "growth factors. now confirmed to play a major role in causing these diseases. Statements made in this news release, other than statements of historical fact, are forward-looking statements and are subject to a number of uncertainties that could cause actual results to differ materially from the statements made, including risks associated with the success of clinical trials, the progress of research and product development programs, the regulatory approval process, competitive products, future capital requirements and the extent and breadth of the company's patent portfolio. See the company's public filings with the Securities and Exchange Commission for information about risks that may affect the company. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion